Evidence map›Paper›PMID 26553230›Full record

ReviewHypertension (Dallas, Tex. : 1979)2016

Nox and Inflammation in the Vascular Adventitia.

Daniel N Meijles, Patrick J Pagano

Open access · bronzeAbstract readReview
In one paragraph

Review in Hypertension (Dallas, Tex. : 1979), 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
3.2field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 52 citations in OpenAlex.

  1. Review
  2. Review
  3. Metabolic Responses to Redox Stress in Vascular Cells.Antioxidants & redox signaling · 2024
    Review
  4. Article
  5. Article
  6. Pulmonary Vascular Remodeling in Pulmonary Hypertension.Journal of personalized medicine · 2023
    Review
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Ponatinib and other CML Tyrosine Kinase Inhibitors in Thrombosis.International journal of molecular sciences · 2020
    Review
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Daniel N MeijlesFrom the Department of Pharmacology and Chemical Biology, Vascular Medicine Institute, University of Pittsburgh, PA.
Patrick J PaganoFrom the Department of Pharmacology and Chemical Biology, Vascular Medicine Institute, University of Pittsburgh, PA. pagano@pitt.edu.
University of Pittsburgh · US

Funding

Vascular Subphenotypes of Lung DiseaseP01HL103455 · NHLBI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI GLADWIN, MARK T · 2011 to 2020
$26.1M
Reactive Oxygen Species in Vascular DiseaseR01HL079207 · NHLBI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI PAGANO, PATRICK J · 2007 to 2018
$3.4M
TSP-1 and ROS: CD47 and SIRP-alpha as Mediators of Vascular DysfunctionR01HL112914 · NHLBI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI ISENBERG, JEFFREY S, PAGANO, PATRICK J · 2013 to 2016
$1.7M
NHLBI NIH HHS P01 HL103455NHLBI NIH HHS P01HL103455-04NHLBI NIH HHS R01 HL079207NHLBI NIH HHS R01 HL112914NHLBI NIH HHS R01HL112914
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AdventitiaBlood VesselsHumansNADPH OxidasesReactive Oxygen SpeciesVasculitisNADPH OxidasesReactive Oxygen Species

Identifiers

PMID26553230
PMCPMC4750106
OpenAlexW2190857649

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.